FLEN PHARMA Trademark

Trademark Overview


On Wednesday, February 25, 2015, a trademark application was filed for FLEN PHARMA with the United States Patent and Trademark Office. The USPTO has given the FLEN PHARMA trademark a serial number of 79167184. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 23, 2022. This trademark is owned by Flen Pharma Group, sociéte anonyme. The FLEN PHARMA trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Commercial trading and consumer information services in the field of wound-treatment and pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; demonstration of goods for advertising and promotional purposes; wholesale store and retail store services of pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; consultancy and providing information regarding the aforesaid services, via the internet or otherwise, online or via other electronic channels

Consultation services in the field of biotechnology, pharmaceutical research and development; scientific analysis services in the field of biotechnology, pharmaceutical research and development, diagnostics, and drug therapy for the purpose of developing wound-treatment products, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; biological and pharmaceutical research and development services for others; clinical research in the field of wound-treatment and pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; pharmaceutical product evaluation; research on the subject of pharmaceuticals; pharmaceutical research and development services; pharmaceutical drug development services; laboratory research in the field of analytical and medicinal chemistry, biology, pharmacology and toxicology; clinical development services, namely, services related to ...
flen pharma

General Information


Serial Number79167184
Word MarkFLEN PHARMA
Filing DateWednesday, February 25, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 23, 2022
Registration Number4911439
Registration DateTuesday, March 8, 2016
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 22, 2015

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCommercial trading and consumer information services in the field of wound-treatment and pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; demonstration of goods for advertising and promotional purposes; wholesale store and retail store services of pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; consultancy and providing information regarding the aforesaid services, via the internet or otherwise, online or via other electronic channels
Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesConsultation services in the field of biotechnology, pharmaceutical research and development; scientific analysis services in the field of biotechnology, pharmaceutical research and development, diagnostics, and drug therapy for the purpose of developing wound-treatment products, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; biological and pharmaceutical research and development services for others; clinical research in the field of wound-treatment and pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; pharmaceutical product evaluation; research on the subject of pharmaceuticals; pharmaceutical research and development services; pharmaceutical drug development services; laboratory research in the field of analytical and medicinal chemistry, biology, pharmacology and toxicology; clinical development services, namely, services related to pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 23, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFlen Health Group S.A.
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressLU

Party NameFlen Pharma Group, sociéte anonyme
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressLU

Party NameFlen Pharma Group, sociéte anonyme
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressLU

Trademark Events


Event DateEvent Description
Friday, July 21, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Friday, June 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, June 23, 2023INVALIDATION PROCESSED
Tuesday, May 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 23, 2022CANCELLED SECTION 71
Monday, March 8, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, January 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 7, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 31, 2017CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 23, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 20, 2016GENERIC MADRID TRANSACTION SENT TO IB
Monday, June 20, 2016GENERIC MADRID TRANSACTION CREATED
Wednesday, June 8, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 8, 2016REGISTERED-PRINCIPAL REGISTER
Monday, January 4, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 22, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2015PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 16, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 2, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 13, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, October 13, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 13, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, October 13, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 29, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, September 29, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 29, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, September 29, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, September 24, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 24, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Saturday, July 18, 2015REFUSAL PROCESSED BY IB
Tuesday, June 30, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 30, 2015REFUSAL PROCESSED BY MPU
Tuesday, June 30, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 30, 2015APPLICATION FILING RECEIPT MAILED
Monday, June 29, 2015NON-FINAL ACTION WRITTEN
Wednesday, June 24, 2015ASSIGNED TO EXAMINER
Wednesday, June 24, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 18, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB